Delivery Order SPE2DB22D2007-SPE2DB24FH7SY
Award Date 12/7/23
Potential Completion Date 12/29/23
Potential Value $7.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $17,009.24 delivery order to AmerisourceBergen Drug Corp for Tecentriq 840 mg/14 ml vials on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a major distribution hub for federal pharmaceutical...
- The Defense Logistics Agency awarded a $17,009.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for supply of Tecentriq (atezolizumab) 840 mg/14 mL vials on May 19, 2025, with completion targeted for June 10, 2025. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, which carries a $999,999,999 ceiling and runs through December 2026. The pharmaceutical distributor is...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $34,018.40 contract is for the supply of 840 mg/14 ml vials of the cancer medication Tecentriq. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies in support of military...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Tecentriq (atezolizumab) 840 mg/14 mL vials. The contract, valued at $8,962.54, is a firm fixed-price delivery order with an ultimate completion date of December 19, 2025. This award represents a non-competitive, competitively awarded delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $35,957.28 to supply TECVAYLI 153 MG/1.7 ML vials. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 7, 2023. As a prime contractor supporting DLA medical supply programs, Amerisourcebergen routinely provides pharmaceuticals and medical materials to military treatment facilities on...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at one thousand three hundred twenty-seven dollars and seventy cents ($1,327.70) by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical). Performance will take place in Conshohocken, Pennsylvania by December 6, 2023. No set aside designation was applied to this award. As the prime contractor, Amerisourcebergen Drug Corp will utilize its Corporate Office division to supply unspecified...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order valued at $22,618.74 from the Defense Logistics Agency Troop Support Medical to supply Ocrevus 300 MG/10 ML vials. The order was awarded on October 25, 2023 under the company's indefinite delivery contract with no set-aside designation specified. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania with completion by November 16, 2023. As a leading pharmaceutical distributor,...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $7,725.64 from the Defense Logistics Agency Troop Support Medical to supply pharmaceutical products and medical supplies. With performance at Amerisourcebergen's Conshohocken, Pennsylvania headquarters, the order was awarded under an indefinite delivery contract through December 2023 to support military treatment programs. No set aside designation was applied. As a leading pharmaceutical distributor, Amerisourcebergen...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $30,082.20 from the Defense Logistics Agency Troop Support Medical to supply pharmaceutical products and medical supplies. With a completion date of November 29, 2023, this order was awarded against the prime vendor's existing indefinite delivery contract with no set-aside designation used. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania. As a leading pharmaceutical...
- Amerisourcebergen Drug Corp has received a $15,058.32 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply IMFINZI 500 MG/10 ML VIAL 10ML pharmaceutical products. Performance will occur at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all work to be completed by January 10, 2024. No set-aside designation was applied to this award made against an existing DLA contract vehicle. As a leading pharmaceutical distributor,...